Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Russia

Russia Articles

Industry

The Federal Antimonopoly Service's decision, to block a proposed merger between Abbott Laboratories Petrovax Pharm, while unexpected, does not signal a worsening investment climate... 2013-04-22


Industry

BMI View: Moves by Russia's Ministry of Industry and Trade to liberalise the over-the-counter (OTC) medicine sector are coming to fruition, with the Health Ministry having the final... 2013-04-03


Industry

BMI View: While drug imports may have declined in 2012, we believe the innovation gap between multinational and Russian drugmakers will continue to favour the multinationals. Russia's... 2013-03-22


More ARTICLES

Industry

BMI View: While the Russian state has enacted drastic changes that increase contributions from citizens towards the cost of healthcare, its guarantees towards pensioners, whose numbers... 2013-03-15


Industry

BMI View: Indian drugmakers recognising the growth potential of the Russian market are continuing their pursuit of localising production in the country. Strong historic and geopolitical... 2013-03-14


Industry

BMI View: Pharmaceutical companies have typically targeted Russian state and regional procurement bids for expensive medicines as their revenue earners in the market. This is despite... 2013-03-08


Industry

BMI View: The recent escalation in the tussle over imatinib highlights the need for Russian authorities to reform the Ministry of Health, public procurement and competition laws. The... 2013-02-25


Industry

BMI View: The recent change to Russia's reference pricing mechanism contradicts the government's goals for the domestic pharmaceutical industry. Introducing India and China as reference... 2013-02-14

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries